Study of ACTR707 in Combination With Rituximab in Subjects With Relapsed or Refractory B Cell Lymphoma
Clinical trial NCT03189836 · TERMINATED
Trial details
- NCT number
- NCT03189836
- Sponsor
- Cogent Biosciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-04
- Primary completion
- 2020-09-21
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.